These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14624)

  • 1. Age and the antihypertensive effectiveness of beta-blockers.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):57-9. PubMed ID: 14624
    [No Abstract]   [Full Text] [Related]  

  • 2. A beta-blocker-based antihypertensive drug program guided by age and renin.
    Bühler FR; Lütold BE
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):29-36. PubMed ID: 14622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ambulant and stationary determination of the renin-sodium index in the classification and treatment of essential hypertension].
    Bühler FR; Patel U; Marbet G
    Schweiz Med Wochenschr; 1974 Dec; 104(49):1802-5. PubMed ID: 4156423
    [No Abstract]   [Full Text] [Related]  

  • 5. Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients.
    Bühler FR; Bolli P; Kiowski W; Erne P; Hulthén UL; Block LH
    Am J Med; 1984 Aug; 77(2A):36-42. PubMed ID: 6148011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin kinetics in hypertension: effect of propranolol and penbutolol.
    Hauger-Klevene JH; Levin GM
    Medicina (B Aires); 1976; 36(3):212-8. PubMed ID: 9557
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-blocking agents in the treatment of hypertension.
    Stumpe KO; Kolloch RE
    Compr Ther; 1977 May; 3(5):55-65. PubMed ID: 16724
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-blockers and plasma renin activity in hypertension.
    Stokes GS; Weber MA; Thornell IR
    Br Med J; 1974 Jan; 1(5897):60-2. PubMed ID: 4149613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renin and age, determinants of the beta-blocker effect in essential hypertension].
    Bühler FR
    Adv Clin Pharmacol; 1976; 11():42-53. PubMed ID: 25569
    [No Abstract]   [Full Text] [Related]  

  • 10. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Effects of beta-adrenergic blockade with propranolol.
    N Engl J Med; 1975 Apr; 292(14):755-6. PubMed ID: 234594
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adrenergic beta receptor blockaders in arterial hypertension].
    Rodríguez-Navarro CQ; Maceira Cruz B; Fernández Andrade C; Ortega Amaya J; Garcia de Pesquera F; López Solbes R; Castilla Jiménez J; Mateos Aguilar J
    Rev Clin Esp; 1975 Nov; 139(4):345-51. PubMed ID: 1828
    [No Abstract]   [Full Text] [Related]  

  • 14. Prorenin and beta-blockade in hypertension.
    McKenna F; Davison AM
    Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].
    Weidmann P; Beretta-Piccoli C; Ziegler W; Hirsch D; de Châtel RD; Reubi FC
    Klin Wochenschr; 1976 Aug; 54(16):765-73. PubMed ID: 8663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressor responses to antihypertensive drug types.
    Alderman MH; Cohen HW; Sealey JE; Laragh JH
    Am J Hypertens; 2010 Sep; 23(9):1031-7. PubMed ID: 20725055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Tailored" application of beta-blockers in hypertension: a continuing dilemma.
    Birkenhäger WH; de Leeuw PW; Wester A; Kho TL; Vandongen R; Falke HE
    Neth J Med; 1977; 20(3):116-22. PubMed ID: 18688
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness.
    Esler MD; Nestel PJ
    Br Heart J; 1973 May; 35(5):469-74. PubMed ID: 4146053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Essential arterial hypertension with low renin].
    Conte G; Semplicini A
    Recenti Prog Med; 1980 Mar; 68(3):280-5. PubMed ID: 6117117
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.